Drug Profile
Erythropoietin biosimilar - Afrivax
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator AfriVax
- Class Antianaemics; Erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anaemia